Drug Profile


Alternative Names: Arebrox; Summair; Z 1170

Latest Information Update: 15 Jun 1995

Price : $50

At a glance

  • Originator Zambon Group SpA
  • Class Bronchodilators
  • Mechanism of Action Beta 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma

Most Recent Events

  • 15 Jun 1995 Discontinued-II for Asthma in Sweden (PO)
  • 15 Jun 1995 Discontinued-III for Asthma in Belgium (PO)
  • 15 Jun 1995 Discontinued-III for Asthma in France (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top